169 related articles for article (PubMed ID: 12800235)
1. Cross-reactivity of hypervariable region 1 chimera of hepatitis C virus.
Xiu BS; Ling SG; Song XG; Zhang HQ; Chen K; Zhu CX
World J Gastroenterol; 2003 Jun; 9(6):1256-60. PubMed ID: 12800235
[TBL] [Abstract][Full Text] [Related]
2. Expression of hepatitis C virus hypervariable region 1 and its clinical significance.
Zhang XX; Zhang SY; Liu J; Lu ZM; Wang Y
World J Gastroenterol; 2003 May; 9(5):1003-7. PubMed ID: 12717846
[TBL] [Abstract][Full Text] [Related]
3. The hypervariable region 1 protein of hepatitis C virus broadly reactive with sera of patients with chronic hepatitis C has a similar amino acid sequence with the consensus sequence.
Watanabe K; Yoshioka K; Ito H; Ishigami M; Takagi K; Utsunomiya S; Kobayashi M; Kishimoto H; Yano M; Kakumu S
Virology; 1999 Nov; 264(1):153-8. PubMed ID: 10544140
[TBL] [Abstract][Full Text] [Related]
4. Development of a plant-derived subunit vaccine candidate against hepatitis C virus.
Nemchinov LG; Liang TJ; Rifaat MM; Mazyad HM; Hadidi A; Keith JM
Arch Virol; 2000; 145(12):2557-73. PubMed ID: 11205105
[TBL] [Abstract][Full Text] [Related]
5. Broadly cross-reactive mimotope of hypervariable region 1 of hepatitis C virus derived from DNA shuffling and screened by phage display library.
Zhang XX; Deng Q; Zhang SY; Liu J; Cai Q; Lu ZM; Wang Y
J Med Virol; 2003 Dec; 71(4):511-7. PubMed ID: 14556263
[TBL] [Abstract][Full Text] [Related]
6. Immune Reactivity of Synthetic Peptides Originated from Hypervariable Region 1 of Hepatitis C Synthetic Consensuses with Egyptian Sera Infected with Hepatitis C Virus Type 4.
Abdel-Fattah M; Charmy R; Tawfik AR
Intervirology; 2015; 58(4):232-41. PubMed ID: 26330263
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of cross-reactive antibody response to HVR1 in chronic hepatitis C.
Xiu BS; Feng XY; He J; Wang GH; Zhang XY; Zhang HQ; Song XG; Chen K; Ling SG; Zhu CX; Wei L; Rao HY
World J Gastroenterol; 2010 Sep; 16(35):4460-6. PubMed ID: 20845515
[TBL] [Abstract][Full Text] [Related]
8. Ontogeny of hepatitis C virus (HCV) hypervariable region 1 (HVR1) heterogeneity and HVR1 antibody responses over a 3 year period in a patient infected with HCV type 2b.
Majid A; Jackson P; Lawal Z; Pearson GM; Parker H; Alexander GJ; Allain JP; Petrik J
J Gen Virol; 1999 Feb; 80 ( Pt 2)():317-325. PubMed ID: 10073690
[TBL] [Abstract][Full Text] [Related]
9. Construction and characterization of an HCV-derived multi-epitope peptide antigen containing B-cell HVR1 mimotopes and T-cell conserved epitopes.
Gao J; Gong Y; Zhao P; Zhu Q; Yang X; Qi Z
Sci China C Life Sci; 2006 Oct; 49(5):490-9. PubMed ID: 17172057
[TBL] [Abstract][Full Text] [Related]
10. Murine antibodies against E2 and hypervariable region 1 cross-reactively capture hepatitis C virus.
Esumi M; Ahmed M; Zhou YH; Takahashi H; Shikata T
Virology; 1998 Nov; 251(1):158-64. PubMed ID: 9813211
[TBL] [Abstract][Full Text] [Related]
11. Towards a solution for hepatitis C virus hypervariability: mimotopes of the hypervariable region 1 can induce antibodies cross-reacting with a large number of viral variants.
Puntoriero G; Meola A; Lahm A; Zucchelli S; Ercole BB; Tafi R; Pezzanera M; Mondelli MU; Cortese R; Tramontano A; Galfre' G; Nicosia A
EMBO J; 1998 Jul; 17(13):3521-33. PubMed ID: 9649423
[TBL] [Abstract][Full Text] [Related]
12. Role of the E2 Hypervariable Region (HVR1) in the Immunogenicity of a Recombinant Hepatitis C Virus Vaccine.
Law JLM; Logan M; Wong J; Kundu J; Hockman D; Landi A; Chen C; Crawford K; Wininger M; Johnson J; Mesa Prince C; Dudek E; Mehta N; Tyrrell DL; Houghton M
J Virol; 2018 Jun; 92(11):. PubMed ID: 29540595
[TBL] [Abstract][Full Text] [Related]
13. Human recombinant single-chain antibody fragments, specific for the hypervariable region 1 of hepatitis C virus, from immune phage-display libraries.
Zhai W; Davies J; Shang DZ; Chan SW; Allain JP
J Viral Hepat; 1999 Mar; 6(2):115-24. PubMed ID: 10607222
[TBL] [Abstract][Full Text] [Related]
14. Mimotopes of the hepatitis C virus hypervariable region 1, but not the natural sequences, induce cross-reactive antibody response by genetic immunization.
Zucchelli S; Roccasecca R; Meola A; Ercole BB; Tafi R; Dubuisson J; Galfré G; Cortese R; Nicosia A
Hepatology; 2001 Mar; 33(3):692-703. PubMed ID: 11230750
[TBL] [Abstract][Full Text] [Related]
15. Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment.
Zibert A; Schreier E; Roggendorf M
Virology; 1995 Apr; 208(2):653-61. PubMed ID: 7538251
[TBL] [Abstract][Full Text] [Related]
16. Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies.
Vietheer PT; Boo I; Drummer HE; Netter HJ
Antivir Ther; 2007; 12(4):477-87. PubMed ID: 17668556
[TBL] [Abstract][Full Text] [Related]
17. [Cross reactivity of mimotopes of hepatitis C virus hypervariable region 1].
Yang M; Zhao P; Bian ZQ; Ren YL; Gong YP; Qi ZT
Bing Du Xue Bao; 2008 Jul; 24(4):249-54. PubMed ID: 18780625
[TBL] [Abstract][Full Text] [Related]
18. In vivo and in vitro evidence that cross-reactive antibodies to C-terminus of hypervariable region 1 do not neutralize heterologous hepatitis C virus.
Esumi M; Zhou YH; Tanoue T; Tomoguri T; Hayasaka I
Vaccine; 2002 Aug; 20(25-26):3095-103. PubMed ID: 12163260
[TBL] [Abstract][Full Text] [Related]
19. Multiple sequence-reactive antibodies induced by a single peptide immunization with hypervariable region 1 of hepatitis C virus.
Zhou YH; Moriyama M; Esumi M
Virology; 1999 Apr; 256(2):360-70. PubMed ID: 10191201
[TBL] [Abstract][Full Text] [Related]
20. High prevalence of hypervariable region 1-specific and -cross-reactive CD4(+) T cells in HCV-infected individuals responsive to IFN-alpha treatment.
Del Porto P; Puntoriero G; Scottà C; Nicosia A; Piccolella E
Virology; 2000 Apr; 269(2):313-24. PubMed ID: 10753710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]